Kuei-Ying Lin

USPTO Granted Patents = 35 (Patent Applications = 6)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 3.5

ph-index = 19

Forward Citations = 2,985(Granted Patents)

Location History:

Fremont, CA (US) (1993 - 2011)
Sunnyvale, CA (US) (2010 - 2017)

Company Filing History:

25 out of 919

Gilead Sciences, Inc.

patents

9 out of 1,035

Isis Pharmaceuticals, Inc.

Years Active: 1993-2017

Loading Chart...

35 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9579332 - Phosphonate analogs of HIV inhibitor compounds (2017-02-28),

2. 9457035 - Antiviral compounds (2016-10-04),

3. 8697861 - Antiviral compounds (2014-04-15),

4. 8329926 - Antiviral compounds (2012-12-11),

5. 8318701 - Phosphonate analogs of HIV inhibitor compounds (2012-11-27),

6. 7871991 - Phosphonate analogs of HIV inhibitor compounds (2011-01-18),

7. 7842672 - Phosphonate inhibitors of HCV (2010-11-30),

8. 7649015 - Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds (2010-01-19),

9. 7645747 - Therapeutic phosphonate compounds (2010-01-12),

10. 7511125 - Pyrimidine derivatives for labeled binding partners (2009-03-31),

11. 7452901 - Anti-cancer phosphonate analogs (2008-11-18),

12. 7439350 - Nucleotide analogs (2008-10-21),

13. 7432261 - Anti-inflammatory phosphonate compounds (2008-10-07),

14. RE39324 - Pyrimidine derivatives and oligonucleotides containing same (2006-10-02),

15. 6967079 - Pyrimidine derivatives for labeled binding partners (2005-11-22),

Title: The Innovative Journey of Inventor Kuei-Ying Lin

Introduction:

Inventor Kuei-Ying Lin, based in Fremont, CA (US), is a prolific inventor with an impressive portfolio of 35 patents. Lin's groundbreaking work has primarily focused on antiviral compounds, particularly phosphonate analogs of HIV inhibitor compounds. Let's delve into the remarkable career of this inventive mind.

Latest Patents:

Lin's latest patents showcase his expertise in developing phosphorus substituted anti-viral inhibitory compounds. One of his recent inventions includes phosphonate analogs of HIV inhibitor compounds. This invention not only introduces novel compounds but also encompasses therapeutic methods involving the administration of these compounds, along with processes and intermediates for their preparation. Another notable patent revolves around antiviral compounds, further solidifying Lin's contribution to the field of antiviral therapeutics.

Career Highlights:

Throughout his career, Kuei-Ying Lin has made significant contributions while working at esteemed companies in the pharmaceutical and biotechnology sector. Notably, he has been associated with Gilead Sciences, Inc. and Isis Pharmaceuticals, Inc., where his innovative spirit and scientific acumen have been instrumental in driving groundbreaking research and development initiatives.

Collaborations:

In his journey of innovation, Lin has collaborated with esteemed professionals in the field. Among his notable coworkers are Mark D. Matteucci and Richard L. Mackman. These collaborations have not only enriched his work but have also fostered a culture of innovation and knowledge-sharing within the scientific community.

Conclusion:

In conclusion, Kuei-Ying Lin's inventive prowess and dedication to developing novel antiviral compounds have left a lasting impact on the field of pharmaceuticals. His trailblazing work in patenting phosphorus substituted compounds stands as a testament to his relentless pursuit of innovation and scientific excellence. Lin's commitment to advancing antiviral therapeutics continues to inspire and pave the way for future advancements in the domain.

This text is generated by artificial intelligence and may not be accurate.